3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
8
Triple Negative Breast Neoplasms
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Borderline Resectable Pancreatic Adenocarcinoma
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
Fluorouracil
10
Oxaliplatin
8
Capecitabine
8
pembrolizumab
6
Specimen Handling
6
Nivolumab
6
Leucovorin
6
trastuzumab deruxtecan
5
Magnetic Resonance Spectroscopy
5
Paclitaxel
4
Cisplatin
4
Biopsy
4
fludarabine
3
aldesleukin
3
Trastuzumab
3
Cyclophosphamide
3
zolbetuximab
2
fludarabine phosphate
2
Ramucirumab
2
Folfox protocol
2
Docetaxel
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.